VPD-737 for Treatment of Chronic Pruritus
| Status: | Completed |
|---|---|
| Conditions: | Allergy |
| Therapuetic Areas: | Otolaryngology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 7/11/2015 |
| Start Date: | October 2013 |
| End Date: | August 2014 |
| Contact: | Michael Dunn |
| Phone: | 201-587-0500 |
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
A study of a several doses of a novel treatment for chronic itch compared to placebo for
patients whose condition has not responded to other treatments
patients whose condition has not responded to other treatments
The sensation of itch is transmitted to the brain through the nervous system Several
chemicals are involved in transmitting this signal This trial of VPD 737 is intended to
treat this condition by blocking one of the chemicals involved in the transmission of the
itch signal This is an oral drug administered once daily It has been used in other trials
and has shown to be safe at the doses used in this trial The trial will involve once daily
pills for 6 weeks. Subject will be asked to fill out questionnaires both electronically
and on paper during the study period Patients will also be monitored for safety and will
have blood taken for testing and several points during the trial Overall participation
will last about 12 weeks
chemicals are involved in transmitting this signal This trial of VPD 737 is intended to
treat this condition by blocking one of the chemicals involved in the transmission of the
itch signal This is an oral drug administered once daily It has been used in other trials
and has shown to be safe at the doses used in this trial The trial will involve once daily
pills for 6 weeks. Subject will be asked to fill out questionnaires both electronically
and on paper during the study period Patients will also be monitored for safety and will
have blood taken for testing and several points during the trial Overall participation
will last about 12 weeks
Inclusion Criteria:
- Clinical diagnosis of chronic pruritus and unresponsive to current therapies
Exclusion Criteria:
- Have chronic liver or renal disease
We found this trial at
25
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
7810 Louis Pasteur
San Antonio, Texas 78229
San Antonio, Texas 78229
210-692-1382
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Quality Clinical Research, Inc. Welcome to Quality Clinical Research. We originated here in Omaha, NE...
Click here to add this to my saved trials
Click here to add this to my saved trials
Temple University Temple University is many things to many people. A place to pursue life's...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials